BridgePort Financial Solutions LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 586 shares of the medical equipment provider's stock, valued at approximately $330,000.
Several other institutional investors have also made changes to their positions in the stock. Sycomore Asset Management lifted its position in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after acquiring an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. lifted its position in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares during the last quarter. Castleark Management LLC lifted its position in shares of Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after buying an additional 2,990 shares during the last quarter. Truist Financial Corp lifted its position in shares of Intuitive Surgical by 3.0% during the 4th quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock worth $129,494,000 after buying an additional 7,298 shares during the last quarter. Finally, Global X Japan Co. Ltd. lifted its position in shares of Intuitive Surgical by 9.8% during the 4th quarter. Global X Japan Co. Ltd. now owns 46,289 shares of the medical equipment provider's stock worth $24,161,000 after buying an additional 4,140 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Stock Up 0.6%
ISRG stock traded up $3.34 during trading on Thursday, hitting $555.75. 1,139,141 shares of the company's stock traded hands, compared to its average volume of 1,646,143. The firm has a market capitalization of $199.19 billion, a P/E ratio of 86.70, a PEG ratio of 5.85 and a beta of 1.70. The business has a fifty day simple moving average of $514.87 and a two-hundred day simple moving average of $538.30. Intuitive Surgical, Inc. has a 1 year low of $396.48 and a 1 year high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the company earned $1.50 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Insider Activity
In other news, CFO Jamie Samath sold 188 shares of the business's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the transaction, the chief financial officer now owns 7,162 shares of the company's stock, valued at $4,060,424.28. The trade was a 2.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,299 shares of company stock valued at $15,470,640 over the last ninety days. 0.70% of the stock is currently owned by insiders.
Analyst Ratings Changes
A number of equities analysts have issued reports on ISRG shares. Royal Bank of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Truist Financial cut their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Piper Sandler dropped their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Barclays cut their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Finally, Erste Group Bank cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $596.05.
Check Out Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.